Tenaya Therapeutics, Inc. (TNYA)
0.70
+0.03
(+4.95%)
USD |
NASDAQ |
Dec 18, 10:59
Tenaya Therapeutics Enterprise Value: 66.27M for Dec. 17, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Applied Therapeutics, Inc. | 7.871M |
| HeartBeam, Inc. | 103.89M |
| CEL-SCI Corp. | 25.20M |
| AIM ImmunoTech, Inc. | 0.953M |
| IGC Pharma, Inc. | 29.53M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -20.28M |
| Total Expenses (Quarterly) | 20.28M |
| EPS Diluted (Quarterly) | -0.1241 |
| Earnings Yield | -112.5% |
| Normalized Earnings Yield | -112.50 |